Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age

Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age

To determine the Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age.

Our study will compare the Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age as in our population compliance with oral medication is better among patients, and is socially and culturally more acceptable.

Inclusion Criteria:

• Age:02 to 05 Years of Age
• both genders will be included.
• patients diagnosed with allergic rhinitis.

Exclusion Criteria:

• patients older than 05 years of age
• a positive history of HIV,TB,Immune deficiency.
• any nasal structural abnormality i.e.polyps,deviated nasal septum.
• history of frequent nasal bleeding,epistaxis.
• concomitant asthma.